Scientific conclusions of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency and the grounds for amending the registration materials/instructions for medical use of medicinal products containing dexamethasone
16.10.2023
1813
In accordance with paragraph 8 of Section IV of the Procedure for conducting expert evaluation, the applicant must amend the instruction for medical use of the medicinal product…
Read more
